Patent details

EP3037424 Title: NOVEL QUINOLINE-SUBSTITUTED COMPOUND

Basic Information

Publication number:
EP3037424
PCT Application Number:
JP2014071951
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148372105
PCT Publication Number:
WO2015025936
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL QUINOLINE-SUBSTITUTED COMPOUND
French Title of Invention:
NOUVEAU COMPOSÉ SUBSTITUÉ PAR UNE QUINOLINE
German Title of Invention:
NEUARTIGE CHINOLINSUBSTITUIERTE VERBINDUNG
SPC Number:

Dates

Filing date:
22/08/2014
Grant date:
08/11/2017
EP Publication Date:
29/06/2016
PCT Publication Date:
26/02/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/11/2017
EP B1 Publication Date:
08/11/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/08/2018
Expiration date:
22/08/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/11/2017
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Inventor

1

Name:
UNO, Takao
Address:
Japan (JP)

2

Name:
NONOSHITA, Katsumasa
Address:
Japan (JP)

3

Name:
SHIMAMURA, Tadashi
Address:
Japan (JP)

Priority

Priority Number:
2013172746
Priority Date:
22/08/2013
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/519; A61K 31/55; A61P 35/00; A61P 43/00; C07D 487/14;

Publication

European Patent Bulletin

Issue number:
201745
Publication date:
08/11/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/12/2018 Outgoing Correspondence 1